Format

Send to

Choose Destination
Cancer Detect Prev. 2007;31(5):375-83. Epub 2007 Nov 26.

Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.

Author information

1
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway (MS) K-53, Atlanta, GA 30341, USA. SSabatino@cdc.gov

Abstract

BACKGROUND:

We surveyed primary care providers to evaluate breast cancer risk assessment and management practices.

METHODS:

Primary care providers included staff (attendees, fellows, nurse practitioners) and residents practicing >or=1 session/week in an outpatient general medicine practice or community practices. Of 201 eligible providers, 107 (53%) completed a self-administered questionnaire ascertaining attitudes, perceived barriers, and clinical practices related to assessing and managing breast cancer risk.

RESULTS:

Of providers, 96% mostly or definitely agreed that assessing breast cancer risk was a primary care provider's responsibility. In assessing risk, most providers reported usually or always asking about family history (71%), but fewer usually or always ask about parity (48%), biopsies (40%), or menarche (35%), and most never calculate Gail scores (76%). In managing women at high risk for breast cancer, many providers reported usually or always communicating increased risk to patients (58%) and tailoring screening based on risk (53%); however fewer providers usually or always discuss chemoprevention (13%) or genetic testing (16%) or refer to specialists (35%). Addressing more immediate issues (25%) and lacking confidence in knowledge of risk and risk assessment (20%) were the most commonly reported barriers to assessing risk (n=83).

CONCLUSION:

Primary care providers generally assess breast cancer risk primarily using family history, potentially missing women at increased risk based on other criteria. In addition, although providers tailor screening and refer women at high risk to specialists, they infrequently discuss chemoprevention or genetic testing. Addressing perceived barriers to assessing risk may improve care.

PMID:
18037249
DOI:
10.1016/j.cdp.2007.08.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center